Xuenan Yang

机构：Sinovac Biotech

发表论文 1 篇 · 总被引 4 次 · h-index 1

代表论文

• Safety and immunogenicity of a modified Omicron-adapted inactivated vaccine in healthy adults: a randomized, double-blind, active-controlled Phase III clinical trial (2023 · Frontiers in Immunology · 被引 4)